Your Eye Doctor May Be Able To Spot Dementia Flags Before Memory Problems Start

The eyes are often said to be a window to the soul. This study suggests they may offer a better view of the mind.

Your next eye exam could reveal more than whether you need new glasses. Scientists have discovered that changes in tiny blood vessels at the back of the eye can signal brain damage in mice with a genetic variant linked to dementia. This suggests routine vision checkups may one day serve as an early warning system for cognitive decline in people.

Researchers at The Jackson Laboratory found that retinal blood vessels mirror what’s happening in the brain when cerebrovascular disease develops. The team studied mice carrying MTHFR677C>T, a common genetic variant found in 20% to 40% of people worldwide that has been associated with increased risk for Alzheimer’s disease and vascular dementia.

The researchers wanted to determine if changes in the retina reflect similar changes happening in brain blood vessels. According to their study published in Alzheimer’s & Dementia, the answer is yes.

What Researchers Found in Mouse Eyes

Using standard ophthalmology equipment similar to what eye doctors use in clinics, researchers photographed retinal blood vessels in mice at 6 and 12 months of age. Female mice with the variant showed the most pronounced changes.

The researchers observed twisted vessels and instances where arteries pressed down on veins, narrowing blood flow. Both abnormalities are warning signs doctors already look for when assessing stroke and cardiovascular disease risk in human patients. Arteries in affected mice became narrower while veins grew wider, suggesting the vascular system was struggling with altered blood pressure.

These specific abnormalities appeared at 6 months, while broader loss of small blood vessels didn’t show up until 12 months. The timing matters because twisted vessels and arterial-venous crossings might serve as earlier markers than overall vessel density changes.

Tests of retinal function showed no differences between normal and variant-carrying mice at 6 months, and retinal thickness remained normal. This means blood vessel abnormalities appeared before measurable functional changes, potentially offering a window for intervention.

How a Common Gene Variant Damages Blood Vessels

The MTHFR gene produces an enzyme for processing folate (vitamin B9) and regulating homocysteine, an amino acid that becomes toxic at high levels. When the enzyme works poorly due to this genetic variant, homocysteine accumulates and damages blood vessels throughout the body.

People carrying one or two copies of the variant may have chronically elevated homocysteine levels, especially if their diet lacks sufficient folate. Elevated homocysteine has been associated with increased risk for cardiovascular disease, stroke, and cognitive decline in human studies, though this mouse research doesn’t directly test those outcomes.

The research team found the MTHFR gene active throughout the retina and brain, particularly in blood vessel cells. When they analyzed tissue samples, they discovered the same molecular stress signals in both locations, suggesting the variant creates parallel damage.

From Mice to Potential Human Applications

Retinal imaging is non-invasive, relatively inexpensive, and already part of routine eye care. If future research confirms that retinal vascular changes can predict cerebrovascular disease in humans, ophthalmologists might be able to identify at-risk patients earlier.

Previous studies have linked retinal abnormalities to Alzheimer’s risk in people, and doctors already use retinal vessel patterns to assess cardiovascular disease. What makes this mouse study different is demonstrating that a specific genetic variant causes matching dysfunction in both the eye and brain.

The researchers note several limitations. The mice were maintained on standard laboratory chow with folic acid levels that may not fully compensate for the enzyme deficiency. Additionally, the variant alone doesn’t cause dementia in these animals but rather creates vascular vulnerability that could worsen with other risk factors like aging or high blood pressure.

The team plans to track both brain and retinal blood vessels in the same animals over time to directly correlate changes as disease progresses. They also want to introduce additional Alzheimer’s-related genetic changes to better model human disease.

While this research is still in early stages and conducted in mice, it establishes biological plausibility for using eye exams to assess brain vascular health.

---

Disclaimer: This article discusses early-stage research in mice and is not medical advice. People concerned about dementia risk or carrying the MTHFR variant should consult their healthcare provider about appropriate screening and management.

---